Tian An Medicare (FRA:SMI) Other Stockholders Equity: €-86.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SMI Tian An Medicare Ltd FRA:SMI
43 GF Score
Price €0.09
GF Value €0.07
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare Other Stockholders Equity?

Tian An Medicare FRA:SMI 43 Other Stockholders Equity is €-86.8 Mil as of Dec. 2025. GuruFocus rates FRA:SMI with a GF Score™ of 43/100 and a GF Value™ of €0.07 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Tian An Medicare's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €-86.8 Mil.

Tian An Medicare's quarterly Other Stockholders Equity increased from Dec. 2024 (€-97.9 Mil) to Jun. 2025 (€-86.9 Mil) and increased from Jun. 2025 (€-86.9 Mil) to Dec. 2025 (€-86.8 Mil).

Tian An Medicare's annual Other Stockholders Equity declined from Dec. 2023 (€-92.8 Mil) to Dec. 2024 (€-97.9 Mil) but then increased from Dec. 2024 (€-97.9 Mil) to Dec. 2025 (€-86.8 Mil).

Tian An Medicare Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Tian An Medicare's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tian An Medicare Other Stockholders Equity Chart

Tian An Medicare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -69.54 -95.22 -92.84 -97.92 -86.78

Tian An Medicare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.84 -94.05 -97.92 -86.87 -86.78
FRA:SMI
43GF Score
Tian An Medicare Ltd FRA:SMI
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-86.8 Mil mean?
Tian An Medicare (FRA:SMI) has a Other Stockholders Equity of €-86.8 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tian An Medicare and its competitors.
Is Tian An Medicare's Other Stockholders Equity too high?
Tian An Medicare's current Other Stockholders Equity is €-86.8 Mil. Overall, Tian An Medicare has a GF Score™ of 43/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's Other Stockholders Equity compare to HCA and THC?
Tian An Medicare's Other Stockholders Equity of €-86.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tian An Medicare and its competitors. Tian An Medicare's current Other Stockholders Equity is €-86.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Based on GuruFocus' analysis, Tian An Medicare (FRA:SMI) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.07, compared to a current price of €0.09 — trading 28.6% above its estimated fair value. The current Other Stockholders Equity is €-86.8 Mil. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Tian An Medicare (FRA:SMI), the current Other Stockholders Equity is €-86.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (FRA:SMI) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of €0.09 is trading 28.6% above its estimated GF Value™ of €0.07. GuruFocus considers Tian An Medicare to be Modestly Overvalued.

Key valuation signals for FRA:SMI:

  • Other Stockholders Equity: €-86.8 Mil
  • GF Value™: €0.07 vs. price of €0.09 (28.6% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:SMI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tian An Medicare Business Description

Other Exchanges 00383:Hong Kong
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score

Get the complete analysis for FRA:SMI

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.07
GF Value